Bluejay Diagnostics (BJDX) vs GlucoTrack (GCTK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bluejay Diagnostics is the larger company by market cap ($3.6 million vs $1.1 million), about 3.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BJDX | GCTK |
|---|---|---|
| Share price | $0.8156 | $1.04 |
| Market cap | $3.64M | $1.06M |
| 1-day change | 0.00% | -6.31% |
| EPS (TTM) | $-3.58 | $-123.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.12 | $123.75 |
| 52-week low | $0.755 | $1.03 |
| Distance from 52-week high | -94.60% | -99.16% |
| Average volume | 3.61M | 2.06M |
| Shares outstanding | 4.47M | 1.02M |
| Employees | 6 | 15 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bluejay Diagnostics is about 3.4 times larger than GlucoTrack by market value ($3.64M vs $1.06M).
About Bluejay Diagnostics
BJDX stock →Bluejay Diagnostics, Inc. operates as a medical diagnostics company.
Health Care · Medical/Dental Instruments · 6 employees
About GlucoTrack
GCTK stock →GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Health Care · Medical/Dental Instruments · 15 employees
BJDX vs GCTK FAQ
Which is bigger, Bluejay Diagnostics or GlucoTrack?
Bluejay Diagnostics (BJDX) is larger, with a market capitalization of $3.64M compared with $1.06M for GlucoTrack (GCTK).
Are Bluejay Diagnostics and GlucoTrack in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.